Extinction models for cancer stem cell therapy.
暂无分享,去创建一个
Hua Zhou | Janet S Sinsheimer | Mary Sehl | K. Lange | J. Sinsheimer | Hua Zhou | M. Sehl | Kenneth L Lange
[1] Max S Wicha,et al. Cancer stem cells: an old idea--a paradigm shift. , 2006, Cancer research.
[2] O. Okamoto,et al. Targeting cancer stem cells with monoclonal antibodies: a new perspective in cancer therapy and diagnosis , 2008, Expert review of molecular diagnostics.
[3] S. Karlin,et al. LINEAR GROWTH, BIRTH AND DEATH PROCESSES , 1958 .
[4] M. Copland,et al. Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction. , 2006, Blood.
[5] C. Eaves,et al. Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3. , 2001, Blood.
[6] Kenneth Lange,et al. In the Garden of Branching Processes , 2004, SIAM Rev..
[7] Sean J. Morrison,et al. Asymmetric and symmetric stem-cell divisions in development and cancer , 2006, Nature.
[8] A. Bhandoola,et al. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. , 2007, Cell stem cell.
[9] D. Gillespie. Exact Stochastic Simulation of Coupled Chemical Reactions , 1977 .
[10] J. Dick,et al. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.
[11] Mark W. Dewhirst,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.
[12] N. Goulden,et al. Characterization of acute lymphoblastic leukemia progenitor cells. , 2004, Blood.
[13] M. Carroll,et al. Survival of acute myeloid leukemia cells requires PI3 kinase activation. , 2003, Blood.
[14] C. Jordan. Can we finally target the leukemic stem cells? , 2008, Best practice & research. Clinical haematology.
[15] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[16] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[17] Desmond J. Higham,et al. Modeling and Simulating Chemical Reactions , 2008, SIAM Rev..
[18] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[19] T. E. Harris,et al. The Theory of Branching Processes. , 1963 .
[20] I. Weissman,et al. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] Kenneth Lange,et al. Numerical analysis for statisticians , 1999 .
[22] B. Smith,et al. Immunotherapy for myeloid leukemias: current status and future directions , 2008, Leukemia.
[23] Mohamed H. Sayegh,et al. Identification of cells initiating human melanomas , 2008, Nature.
[24] Derick R. Peterson,et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. , 2005, Blood.
[25] Michael F. Clarke,et al. Applying the principles of stem-cell biology to cancer , 2003, Nature Reviews Cancer.
[26] Samuel Karlin,et al. A First Course on Stochastic Processes , 1968 .
[27] S. Morrison,et al. Efficient tumor formation by single human melanoma cells , 2008, Nature.
[28] Dominik Wodarz,et al. Drug resistance in cancer: principles of emergence and prevention. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[29] T. Papayannopoulou,et al. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. , 1977, The American journal of medicine.
[30] S. Morrison,et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells , 2006, Nature.
[31] Jeffrey M. Rosen,et al. The Increasing Complexity of the Cancer Stem Cell Paradigm , 2009, Science.
[32] Goldie Jh,et al. Quantitative model for multiple levels of drug resistance in clinical tumors. , 1983 .
[33] Utpal Banerjee,et al. The hematopoietic stem cell and its niche: a comparative view. , 2007, Genes & development.
[34] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[35] K. Lange,et al. Differential destruction of stem cells: implications for targeted cancer stem cell therapy. , 2009, Cancer research.
[36] C. Jamieson,et al. Chronic myeloid leukemia stem cells. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Kenneth Lange,et al. Accurate Stochastic Simulation via the Step Anticipation τ-Leaping (SAL) Algorithm , 2009, J. Comput. Biol..
[38] Linda R Petzold,et al. Efficient step size selection for the tau-leaping simulation method. , 2006, The Journal of chemical physics.
[39] Catherine M. Verfaillie,et al. The molecular repertoire of the 'almighty' stem cell , 2005, Nature Reviews Molecular Cell Biology.
[40] J. Goldie,et al. Quantitative model for multiple levels of drug resistance in clinical tumors. , 1983, Cancer treatment reports.
[41] L. Allen. Stem cells. , 2003, The New England journal of medicine.
[42] R. McLendon,et al. Targeting cancer stem cells through L1CAM suppresses glioma growth. , 2008, Cancer research.
[43] Birth and death processes with absorption , 1992 .
[44] M. Caligiuri,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.
[45] Martin A. Nowak,et al. Dynamics of chronic myeloid leukaemia , 2005, Nature.
[46] Ronald L. Graham,et al. Concrete mathematics - a foundation for computer science , 1991 .
[47] I. Shih,et al. Notch Signaling, γ-Secretase Inhibitors, and Cancer Therapy: Figure 1. , 2007 .
[48] P. Cochat,et al. Et al , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[49] E. T. Gawlinski,et al. A reaction-diffusion model of cancer invasion. , 1996, Cancer research.
[50] Serik Sagitov,et al. On the path to extinction , 2007, Proceedings of the National Academy of Sciences.
[51] L. Hayflick. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.
[52] O. Witte,et al. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[53] D. Ambrosi,et al. On the mechanics of a growing tumor , 2002 .
[54] C. Huff,et al. Characterization of clonogenic multiple myeloma cells. , 2004, Blood.
[55] P. Henrici. Fast Fourier Methods in Computational Complex Analysis , 1979 .
[56] Mark Shackleton,et al. Efficient tumour formation by single human melanoma cells , 2008 .
[57] Michael C. Ferris,et al. Optimizing the Delivery of Radiation Therapy to Cancer Patients , 1999, SIAM Rev..
[58] Laurie E Ailles,et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. , 2004, The New England journal of medicine.
[59] D. Kendall. Applied Probability , 1958, Nature.
[60] G. Schuurhuis,et al. MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia , 2004, Leukemia.
[61] T. Ferguson. A Course in Large Sample Theory , 1996 .
[62] D. Gillespie. A General Method for Numerically Simulating the Stochastic Time Evolution of Coupled Chemical Reactions , 1976 .
[63] William Feller,et al. An Introduction to Probability Theory and Its Applications , 1967 .
[64] K. Lange,et al. Mutation Takes No Vacation: Can Structured Treatment Interruptions Increase the Risk of Drug‐Resistant HIV‐1? , 2000, Journal of acquired immune deficiency syndromes.
[65] S. V. Sotirchos,et al. Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH , 1992, Journal of cellular physiology.
[66] Marek Kimmel,et al. Branching processes in biology , 2002 .
[67] Franziska Michor,et al. Successful Therapy Must Eradicate Cancer Stem Cells , 2006, Stem cells.
[68] Feller William,et al. An Introduction To Probability Theory And Its Applications , 1950 .
[69] Peter Guttorp,et al. Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. , 2002, Blood.
[70] E. Caussinus,et al. Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster , 2005, Nature Genetics.
[71] I. Weissman,et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.
[72] Darren J. Wilkinson. Stochastic Modelling for Systems Biology , 2006 .
[73] Ash A. Alizadeh,et al. CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells , 2009, Cell.
[74] D. Gillespie. Approximate accelerated stochastic simulation of chemically reacting systems , 2001 .
[75] B. Thiers,et al. Identification of cells initiating human melanomas , 2009 .
[76] D. Bonnet. Haematopoietic stem cells 1 , 2002, The Journal of pathology.
[77] G. Grimmett,et al. Probability and random processes , 2002 .
[78] Nicolò Riggi,et al. Identification of cancer stem cells in Ewing's sarcoma. , 2009, Cancer research.
[79] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[80] D. Howard,et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. , 2001, Blood.
[81] S. Morrison,et al. The PI-3kinase pathway in hematopoietic stem cells and leukemia-initiating cells: a mechanistic difference between normal and cancer stem cells. , 2008, Blood cells, molecules & diseases.